New Delhi: Chief Scientist Dr Soumya Swaminathan on Monday said India is one of the largest contributors of the global solidarity trial that is aimed to provide robust results on whether a drug can save lives in patients hospitalized with severe or critical COVID-19.
“World Health Organisation (WHO) has set up a global solidarity platform because it recognised that multiple small clinical trials will be done but will not be leading conclusive results,” Dr Swaminathan said during the opening ceremony of the seminar of PANEX-21.